|
[Related PubMed/MEDLINE]
Total Number of Papers: 450
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Advanced magnetic resonance spectroscopic neuroimaging: Experts' consensus recommendations. |
--- |
| 2 |
2020 |
An integrated RF-receive/B0-shim array coil boosts performance of whole-brain MR spectroscopic imaging at 7T. |
--- |
| 3 |
2020 |
Clinical High-Resolution 3D-MR Spectroscopic Imaging of the Human Brain at 7 T. |
CRLBs, CRT, FID |
| 4 |
2020 |
Constrained Magnetic Resonance Spectroscopic Imaging by Learning Nonlinear Low-Dimensional Models. |
--- |
| 5 |
2020 |
Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study. |
ACC, rmANOVA, ROI, tCr |
| 6 |
2020 |
Effects of apodization smoothing and denoising on spectral fitting. |
dnPCA, SNR |
| 7 |
2020 |
Functional Genetic Screening Enables Theranostic Molecular Imaging in Cancer. |
DNP, LDH, LDHi |
| 8 |
2020 |
High-Resolution 3D Spin-Echo MRSI Using Interleaved Water Navigators, Sparse Sampling and Subspace-Based Processing. |
--- |
| 9 |
2020 |
High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI. |
2-HG, Gln, Glu, Gly, HGG, NAA, tCho, tCr |
| 10 |
2020 |
Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy. |
DNP, HCC, TAE |
| 11 |
2020 |
Hyperpolarized [1-13C]pyruvate-to-[1-13C]lactate conversion is rate-limited by monocarboxylate transporter-1 in the plasma membrane. |
LDHA, MCT1, shRNA |
| 12 |
2020 |
Imaging breast cancer using hyperpolarized carbon-13 MRI. |
ILC, LDHA |
| 13 |
2020 |
Improved Low-Rank Filtering of MR Spectroscopic Imaging Data With Pre-Learnt Subspace and Spatial Constraints. |
LORA |
| 14 |
2020 |
Improved reconstruction stability for chemical shift encoded hyperpolarized 13 C magnetic resonance spectroscopic imaging using k-t spiral acquisitions. |
FOV |
| 15 |
2020 |
Monitoring Early Changes in Tumor Metabolism in Response to Therapy Using Hyperpolarized 13C MRSI in a Preclinical Model of Glioma. |
--- |
| 16 |
2020 |
No evidence of abnormal metabolic or inflammatory activity in the brains of patients with rheumatoid arthritis: results from a preliminary study using whole-brain magnetic resonance spectroscopic imaging (MRSI). |
Cho, FDR, HC, Lac, mI, RA |
| 17 |
2020 |
Robust outer volume suppression utilizing elliptical pulsed second order fields (ECLIPSE) for human brain proton MRSI. |
ECLIPSE, ECLIPSE, IR, IVS, OVS, RF |
| 18 |
2020 |
Role of metabolic imaging in diagnosis of primary, metastatic, and recurrent prostate cancer. |
mpMRI, PET |
| 19 |
2020 |
The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas. |
Cho, Cr, GLMs, Glx, IDH, mIno, NAA, VOIs |
| 20 |
2019 |
7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis: How Does Spatial Resolution Affect the Detectability of Metabolic Changes in Brain Lesions? |
MS |
| 21 |
2019 |
A multitransmit external body array combined with a 1 H and 31 P endorectal coil to enable a multiparametric and multimetabolic MRI examination of the prostate at 7T. |
ERC, mpMRI, SAR |
| 22 |
2019 |
Acidosis and cancer: from mechanism to neutralization. |
--- |
| 23 |
2019 |
Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI). |
APT, Cho, MT, MTR, NAA |
| 24 |
2019 |
Cancer metabolism in a snapshot: MRS(I). |
Lac, Pyr |
| 25 |
2019 |
Correlation of Tumor Perfusion Between Carbon-13 Imaging with Hyperpolarized Pyruvate and Dynamic Susceptibility Contrast MRI in Pre-Clinical Model of Glioblastoma. |
DSC, GBM, Gd |
| 26 |
2019 |
Differential neuroimaging indices in prefrontal white matter in prenatal alcohol-associated ADHD versus idiopathic ADHD. |
ACR, ADHD, ADHD-PAE, Cho, DTI, FA, FASD, FDR, PAE |
| 27 |
2019 |
Effects of the antidepressant medication duloxetine on brain metabolites in persistent depressive disorder: A randomized, controlled trial. |
MRI, NAA, PDD, RCT, WM |
| 28 |
2019 |
Fast data acquisition techniques in magnetic resonance spectroscopic imaging. |
--- |
| 29 |
2019 |
HDAC inhibition in glioblastoma monitored by hyperpolarized 13 C MRSI. |
GBM, HDAC, LDH, MCTs |
| 30 |
2019 |
High-resolution metabolic mapping of gliomas via patch-based super-resolution magnetic resonance spectroscopic imaging at 7T. |
MRI, PBSR, PET |
| 31 |
2019 |
In vivo Metabolic Profiles as Determined by 31P and short TE 1H MR-Spectroscopy : No Difference Between Patients with IDH Wildtype and IDH Mutant Gliomas. |
CSI, GPC, GPE, IDHmut, IDHwt, PC, PE |
| 32 |
2019 |
Longitudinal Metabolite Changes after Traumatic Brain Injury: A Prospective Pediatric Magnetic Resonance Spectroscopic Imaging Study. |
cMild, Cr, NAA, TBI |
| 33 |
2019 |
Magnetic resonance spectroscopy imaging in diagnosis of suspicious prostate cancer: A meta-analysis. |
DOR, PC, SROCs |
| 34 |
2019 |
Non-invasive imaging modalities to study neurodegenerative diseases of aging brain. |
DTI, EEG, fMRI, MEG, NIRS, PET, SPECT, TES, TMS |
| 35 |
2019 |
Retrospective motion compensation for edited MR spectroscopic imaging. |
Cho, GABA |
| 36 |
2019 |
Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model. |
--- |
| 37 |
2019 |
Tensor-Based Method for Residual Water Suppression in 1H Magnetic Resonance Spectroscopic Imaging. |
--- |
| 38 |
2019 |
The Role of Lactate Metabolism in Prostate Cancer Progression and Metastases Revealed by Dual-Agent Hyperpolarized 13C MRSI. |
ADC, HP, LDHA, mp, MRI, TRAMP |
| 39 |
2019 |
The Role of Magnetic Resonance Spectroscopy Imaging Parameters to Predict Early Biochemical Recurrence after Radical Prostatectomy. |
AUC, BCR, MRI, PCa, RP |
| 40 |
2019 |
Tissue-type mapping of gliomas. |
mMRI, PDD |
| 41 |
2018 |
A minimum-phase Shinnar-Le Roux spectral-spatial excitation RF pulse for simultaneous water and lipid suppression in 1H-MRSI of body extremities. |
Cho, Cr, SLR, SPSP |
| 42 |
2018 |
Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo. |
CAIX, ISUCA |
| 43 |
2018 |
Comparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma. |
TE |
| 44 |
2018 |
Density-weighted concentric rings k-space trajectory for 1 H magnetic resonance spectroscopic imaging at 7T. |
CRT, DW, EPSI, RE, SNR |
| 45 |
2018 |
High and ultra-high resolution metabolite mapping of the human brain using 1H FID MRSI at 9.4T. |
GABA, Gln, Glu, NAAG, SNR |
| 46 |
2018 |
Hyperpolarized [1-13C]-Pyruvate Magnetic Resonance Spectroscopic Imaging of Prostate Cancer In Vivo Predicts Efficacy of Targeting the Warburg Effect. |
EPR, LDH |
| 47 |
2018 |
Improved spatial localization in magnetic resonance spectroscopic imaging with two-dimensional PSF-Choice encoding. |
PRESS, PSF |
| 48 |
2018 |
Measuring Tumor Metabolism in Pediatric Diffuse Intrinsic Pontine Glioma Using Hyperpolarized Carbon-13 MR Metabolic Imaging. |
DIPG |
| 49 |
2018 |
Metabolite-cycled density-weighted concentric rings k-space trajectory (DW-CRT) enables high-resolution 1 H magnetic resonance spectroscopic imaging at 3-Tesla. |
CRLB, DW-CRT, TE |
| 50 |
2018 |
Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis. |
DTI, MRI, MS, WM |
| 51 |
2018 |
MultiNet PyGRAPPA: Multiple neural networks for reconstructing variable density GRAPPA (a 1H FID MRSI study). |
--- |
| 52 |
2018 |
Non-water-suppressed 1 H FID-MRSI at 3T and 9.4T. |
FID, NAA, SAR, TE |
| 53 |
2018 |
Over-discretized SENSE reconstruction and B0 correction for accelerated non-lipid-suppressed 1 H FID MRSI of the human brain at 9.4 T. |
SAR, SENSE |
| 54 |
2018 |
Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy. |
DIL, GU, HDR |
| 55 |
2018 |
Phosphorus magnetic resonance spectroscopic imaging using flyback echo planar readout trajectories. |
SNR |
| 56 |
2018 |
Reduction of Acquisition time using Partition of the sIgnal Decay in Spectroscopic Imaging technique (RAPID-SI). |
CSI, MRS |
| 57 |
2018 |
Simultaneous 18F-fluciclovine Positron Emission Tomography and Magnetic Resonance Spectroscopic Imaging of Prostate Cancer. |
PET, SUV |
| 58 |
2018 |
Water suppression in the human brain with hypergeometric RF pulses for single-voxel and multi-voxel MR spectroscopy. |
HGWS |
| 59 |
2017 |
A Subspace Approach to Spectral Quantification for MR Spectroscopic Imaging. |
--- |
| 60 |
2017 |
A systematic review on multiparametric MR imaging in prostate cancer detection. |
DCE-MRI, DWI, ERC, MRI, PAC |
| 61 |
2017 |
Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen. |
GBM, RT |
| 62 |
2017 |
Clinical and Magnetic Resonance Spectroscopic Imaging Findings in Veterans With Blast Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder. |
blast mTBI, Ch, GLMs, NAA, PTSD |
| 63 |
2017 |
Combined Diffusion Tensor and Magnetic Resonance Spectroscopic Imaging Methodology for Automated Regional Brain Analysis: Application in a Normal Pediatric Population. |
BG, BS, CC, Cr, DTI, FA, NAA, TH |
| 64 |
2017 |
Compartmentalized low-rank recovery for high-resolution lipid unsuppressed MRSI. |
TE |
| 65 |
2017 |
Detecting neuronal dysfunction of hand motor cortex in ALS: A MRSI study. |
ALS, HC, HMC, MRS, NAA |
| 66 |
2017 |
Fast magnetic resonance spectroscopic imaging techniques in human brain- applications in multiple sclerosis. |
--- |
| 67 |
2017 |
Flexible proton 3D MR spectroscopic imaging of the prostate with low-power adiabatic pulses for volume selection and spiral readout. |
FOVs, GOIA, PRESS, sLASER, TE |
| 68 |
2017 |
Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model. |
HP, MPs, MS |
| 69 |
2017 |
Imaging of Glutamate Concentration in Sturge-Weber Syndrome. |
SWS |
| 70 |
2017 |
Longitudinal MR Spectroscopy Shows Altered Metabolism in Traumatic Brain Injury. |
Cho, NAA |
| 71 |
2017 |
Magnetic resonance spectroscopy and magnetic resonance spectroscopic imaging in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A literature review. |
CADASIL, MRS, RR |
| 72 |
2017 |
Metabolic changes in normal appearing white matter in multiple sclerosis patients using multivoxel magnetic resonance spectroscopy imaging. |
Cho, Cr, MRS, MS, NAA, NAWM, RRMS |
| 73 |
2017 |
Metabolic imaging of energy metabolism in traumatic brain injury using hyperpolarized [1-13C]pyruvate. |
TBI |
| 74 |
2017 |
Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment. |
GBM, TRI |
| 75 |
2017 |
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate. |
DCE, DWI, mpMRI, PC, PZ, SI, T2WI |
| 76 |
2017 |
Multivariate Associations of Fluid Intelligence and NAA. |
NAA, PCA |
| 77 |
2017 |
Non-water-suppressed short-echo-time magnetic resonance spectroscopic imaging using a concentric ring k-space trajectory. |
SNR, STEAM |
| 78 |
2017 |
Nonnegative Canonical Polyadic Decomposition for Tissue-Type Differentiation in Gliomas. |
NCPD |
| 79 |
2017 |
Patch-Based Super-Resolution of MR Spectroscopic Images: Application to Multiple Sclerosis. |
--- |
| 80 |
2017 |
Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging. |
ADC, CG, Cho, Cit, PRESS, PZ, Spm |
| 81 |
2017 |
Spectral Quantification for High-Resolution MR Spectroscopic Imaging With Spatiospectral Constraints. |
--- |
| 82 |
2017 |
Variance components associated with long-echo-time MR spectroscopic imaging in human brain at 1.5T and 3T. |
--- |
| 83 |
2016 |
(31)P CSI of the human brain in healthy subjects and tumor patients at 9.4T with a three-layered multi-nuclear coil: initial results. |
--- |
| 84 |
2016 |
2D AMESING multi-echo (31)P-MRSI of the liver at 7T allows transverse relaxation assessment and T2-weighted averaging for improved SNR. |
AMESING, SNR |
| 85 |
2016 |
Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI. |
cMRI, DWI, HGGs, mpMRI, PWI |
| 86 |
2016 |
Evaluating metabolites in patients with major depressive disorder who received mindfulness-based cognitive therapy and healthy controls using shortecho MRSI at 7 Tesla. |
ACC, MBCT, MDD, NAA, tCr |
| 87 |
2016 |
Imaging increased glutamate in children with Sturge-Weber syndrome: Association with epilepsy severity. |
Cr, Glu, NAA, PET, SWS |
| 88 |
2016 |
Impact of an endorectal coil for 1H-magnetic resonance spectroscopy of the prostate at 3.0T in comparison to 1.5T: Do we need an endorectal coil? |
CSL, ERC, SNR |
| 89 |
2016 |
Improved Low-Rank Filtering of Magnetic Resonance Spectroscopic Imaging Data Corrupted by Noise and B₀ Field Inhomogeneity. |
SNR |
| 90 |
2016 |
Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy. |
IQR |
| 91 |
2016 |
Magnetic resonance spectroscopic imaging at superresolution: Overview and perspectives. |
DFT |
| 92 |
2016 |
Magnetic Resonance Spectroscopy of siRNA-Based Cancer Therapy. |
MRS, siRNA |
| 93 |
2016 |
Metabolic Imaging in Prostate Cancer: Where We Are. |
mpMRI, PCa, PET |
| 94 |
2016 |
MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival. |
GBM, MRS, TMZ |
| 95 |
2016 |
MRSI-based molecular imaging of therapy response to temozolomide in preclinical glioblastoma using source analysis. |
GB, MLs, TMZ |
| 96 |
2016 |
Multiparametric MR can identify high grade prostatic intraepithelial neoplasia (HGPIN) lesions and predict future detection of prostate cancer in men with a negative initial prostate biopsy. |
ADC, DWI, HGPIN, PCa |
| 97 |
2016 |
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer. |
--- |
| 98 |
2016 |
Prostate MRSI predicts outcome in radical prostatectomy patients. |
BCR, CRS, ECE, NHGV, NILV, NPC, NUPV, RP, TF |
| 99 |
2016 |
Reduction of variance in measurements of average metabolite concentration in anatomically-defined brain regions. |
--- |
| 100 |
2016 |
Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab. |
GBM, NAA, OS, PFS, RT |
|
A Search Service for Abbreviation / Long Form
